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Research
Epidemiologic studies have linked elevated 
levels of both gaseous and (ultra-)fine par-
ticulate matter (PM) ambient air pollut-
ants to increased morbidity and mortality 
due to respiratory and cardiovascular disease 
(McCreanor et al. 2007; Peng et al. 2008). 
Underlying biological mechanisms are 
unclear, but inflammation and hemostasis are 
suggested to be involved (Brook et al. 2004; 
Peters et al. 1997; Ruckerl et al. 2006). It has 
been postulated that inhaled gases, and also 
ultrafine PM because of its very small particle 
size (< 0.1 µm), can readily cross the lung epi-
thelium into the bloodstream (Nemmar et al. 
2002). There they can have direct, transient 
systemic effects leading to a prothrombotic 
state, such as enhanced platelet activation and 
thrombin generation (Nemmar et al. 2004; 
Radomski et al. 2005; Seaton et al. 1995). In 
contrast, larger particles that cannot pass the 
alveolar–blood barrier will perturb the lung 
epithelium, where they may give rise to local 
inflammation (Donaldson et al. 2001; Salvi 
et al. 1999). Under experimental conditions, 
human or animal exposure to a controlled 
high dose of air pollutants has been shown to 
cause pulmonary inflammation that leads to 
a systemic release of cytokines. This in turn 
induces de novo synthesis of inflammatory bio-
markers in the liver, such as fibrinogen, which 
also plays a major part in blood clotting, and 
C-reactive protein (CRP). In general, at least 
24 hr elapses from the onset of this protein 
synthesis to a clear increase in plasma levels of 
inflammatory markers (Ruckerl et al. 2007). 
We therefore hypothesized that air pollution 
has both direct and indirect effects on platelet 
aggregation and coagulation, but only indi-
rect effects on plasma levels of the inflamma-
tory variables fibrinogen and CRP.
Previous studies have aimed primarily at 
finding epidemiologic associations between 
concentrations of air pollution and health 
effects, including mortality, or associations 
between experimentally controlled exposures 
to air pollution and various biological vari-
ables in human and animal models (Brook 
2007; Gong 1992). However, studies are still 
lacking that focus on the effect of air pollution 
on hemostasis and inflammation in a real-
life urban situation over a longer period of 
time, especially because continuous long-term 
monitoring shows large variations within each 
year in local concentrations of air pollutants 
(Figure 1) (Brook et al. 2004). Therefore, the 
aim of this study was to investigate longitudi-
nally (i.e., repeatedly over 1 year) the associa-
tions between local urban concentrations of 
ambient air pollution and plasma markers of 
hemostasis and inflammation. In addition, we 
aimed to investigate in vitro whether PM can 
have an effect on platelet aggregation.
Materials and Methods
Study population. Between January 2005 
and December 2006, we included 40 healthy 
individuals who were living or working in the 
city center of Rotterdam, the Netherlands, 
a city agglomerate with almost 1 million 
inhabitants. Exclusion criteria were symp-
toms of chronic infectious diseases, acute 
infections, or any surgical procedure within 
the preceding 3 months. We collected from 
each participant blood at 11–13 (mean, 
12.5) different visits throughout a 1-year 
period. In total, we collected 498 blood 
samples on 197 days. For each subject, the 
minimal interval between successive blood 
collections was 3 days and the maximal inter-
val was 6 months, with a similar pattern of 
distribution in each subject. We collected 
data on demographics and cardiovascular 
risk factors using a standardized question-
naire. To minimize the effect of circadian 
variation on plasma levels of biomarkers, we 
took blood samples between 0900 and 1100 
hours. The study protocol is in accordance 
with the Declaration of Helsinki and was 
approved by the Medical Ethics Committee 
of the Erasmus University Medical Center. 
We obtained written informed consent from 
each participant.
Air pollution monitoring data. We 
obtained concentrations of PM with aero-
dynamic diameter < 10 µm (PM10), car-
bon  monoxide,  nitrogen  monoxide, 
nitrogen dioxide, and ozone from the Dutch 
National Air Quality Monitoring Network 
(National Institute for Public Health and the 
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Ba c k g r o u n d: Air pollution has consistently been associated with increased morbidity and mortality 
due to respiratory and cardiovascular disease. Underlying biological mechanisms are not entirely clear, 
and hemostasis and inflammation are suggested to be involved. 
oBjectives: Our aim was to study the association of the variation in local concentrations of air-
borne particulate matter (PM) with aerodynamic diameter < 10 µm, carbon monoxide, nitrogen 
monoxide, nitrogen dioxide, and ozone with platelet aggregation, thrombin generation, fibrinogen, 
and C-reactive protein (CRP) levels in healthy individuals. 
Me t h o d s : From 40 healthy volunteers, we collected 13 consecutive blood samples within a 1-year 
period and measured light-transmittance platelet aggregometry, thrombin generation, fibrinogen, 
and CRP. We performed regression analysis using generalized additive models to study the associa-
tion between the hemostatic and inflammatory variables, and local environmental concentrations of 
air pollutants for time lags within 24 hr before blood sampling or 24–96 hr before blood sampling. 
re s u l t s: In general, air pollutants were associated with platelet aggregation [average, +8% per 
interquartile range (IQR), p < 0.01] and thrombin generation (average, +1% per IQR, p < 0.05). 
Platelet aggregation was not affected by in vitro incubation of plasma with PM. We observed no 
relationship between any of the air pollutants and fibrinogen or CRP levels. 
co n c l u s i o n s: Air pollution increased platelet aggregation as well as coagulation activity but had no 
clear effect on systemic inflammation. These prothrombotic effects may partly explain the relation-
ship between air pollution and the risk of ischemic cardiovascular disease.
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tion. Environ Health Perspect 117:995–1001 (2009).  doi:10.1289/ehp.0800437 available via http://
dx.doi.org/ [Online 22 February 2009]Rudež et al.
996  v o l u m e  117 | n u m b e r 6 | June 2009  •  Environmental Health Perspectives
Environment 2009), which measured these 
air pollutants hourly at monitoring station 
no. 418 (Schiedamse Vest, Rotterdam, the 
Netherlands). This monitoring site is located 
in the Rotterdam city center and is subject 
to frequent quality control to ensure its abil-
ity to represent urban background air pol-
lution. For data analysis, we calculated 6-hr 
means and then combined them into 12-hr 
and 24-hr means. If more than two hourly 
concentrations were missing for a 6-hr mean, 
we imputed them using data from five other 
monitoring stations of the Dutch National 
Air Quality Monitoring Network that were 
all within 25 km of Rotterdam.
Blood collection. Blood was drawn by 
venipuncture in the antecubital vein using 
the Vacutainer system (Becton Dickinson, 
Plymouth, UK) containing sodium citrate (final 
concentration, 3.2%). Plasma was obtained by 
centrifugation at 1,500g for 10 min at 4°C and 
stored in aliquots at –80°C until further analy-
sis. For platelet aggregation, blood was centri-
fuged at 150g for 15 min to obtain platelet-rich 
plasma (PRP) and subsequently at 1,500g for 
10 min to obtain platelet-poor plasma (PPP). 
We adjusted PRP with autologous PPP to 200 
× 109 platelets/L (P200), which was used in 
platelet aggregation experiments.
Laboratory  measurements.  Light-
transmittance platelet aggregometry. We 
performed adenosine diphosphate (ADP)–
induced light-transmittance platelet aggregom-
etry as described previously (van Gestel et al. 
2003). We chose ADP as the agonist because 
the ADP pathway in platelets plays an impor-
tant role in atherothrombosis (Woulfe et al. 
2001). We preincubated P200 with aspirin 
(100 µmol/L final) for 20 min and brought 
it to a physiologic calcium concentration of 
16.6 mM by adding calcium chloride (CaCl2) 
(Merck & Co., New York, NY, USA) after 
preincubation with the thrombin-inhibitor 
d-phenylalanyl-l-prolyl-l-arginine chloro-
methyl ketone (40 µmol/L, final; Merck & 
Co., Darmstadt, Germany). We induced 
platelet aggregation by 5 and 2.5 µmol/L 
ADP (Sigma Chemical Co., St. Louis, MO, 
USA) and determined maximal aggregation 
and late aggregation (residual aggregation at 
6 min after the maximum representing platelet 
aggregate stability) by recording for 10 min 
on a four-channel optical aggregometer 
(Chrono-log, Kordia Life Sciences, Leiden, 
the Netherlands). Because of logistic reasons, 
platelet aggregation could be performed in 
only a subset of 139 plasma samples from 
16 individuals.
We studied direct in vitro effects of PM 
on platelet aggregation by adding different 
types of diluted PM (reference PM with 
diameter size < 0.1, 2.5, or 10 µm, diesel soot 
collected with a diesel generator, urban back-
ground dust collected from a local baghouse 
filter extract, or EHC-93 reference dust that 
was collected in Ottawa, Ontario, Canada) 
to P200 or whole blood in various concen-
trations (range, 0–100 µg/mL) for different 
incubation periods (range, 0–2 hr) and per-
forming ADP-induced light-transmittance 
or ADP-induced impedance whole-blood 
platelet aggregation experiments (Chrono-
log), respectively. We compared results with 
those obtained with aliquot samples without 
  incubation with PM.
Thrombin  generation.  We  meas-
ured thrombin generation in tissue fac-
tor (TF)-triggered PPP with the calibrated 
automated thrombogram (CAT) method 
(Thrombinoscope, Maastricht, the Netherlands) 
(Hemker et al. 2003). We conducted mea-
surements on 80 µL plasma with final con-
centrations of 1 and 5 pM TF (PPP reagent 
low and PPP reagent; Thrombinoscope) and 
4 µM phospholipids. We obtained thrombin 
calibrator from Thrombinoscope. We read 
fluorescence in a Fluoroskan Ascent reader 
(Thermo Labsystems OY, Helsinki, Finland) 
equipped with a 390/460-nm filter set. We 
calculated thrombin generation curves with the 
Thrombinoscope software. We derived three 
parameters from the thrombin generation 
curves: lag time (defined as the time to reach 
one-sixth of the peak height), endogenous 
thrombin potential (ETP), and peak height. A 
thrombin generation curve is characterized by 
the initial burst of thrombin formation and the 
lag time, which depends on the amount of TF 
present in the sample or added to the plasma to 
trigger coagulation. Furthermore, the lag time 
is negatively associated with the plasma levels 
of factors VII and IX, antithrombin, free pro-
tein S, and free TF pathway inhibitor (Dielis 
et al. 2008). The other two main parameters, 
ETP and peak height, reflect the potential of 
plasma to generate thrombin and have been 
suggested to indicate a state of hypercoagulabil-
ity when elevated (ten Cate-Hoek et al. 2008). 
Both the ETP and peak height are determined 
by plasma levels of fibrinogen, factor XII, 
antithrombin, and free TF pathway inhibitor 
(Dielis et al. 2008).
Fibrinogen and CRP. We determined 
fibrinogen levels according to von Clauss 
(Instrumentation Laboratory, IJsselstein, 
the Netherlands) and the prothrombin 
(PT)-derived method (Dade Thrombin 
Reagent, Siemens Diagnostics, Leusden, the 
Netherlands) on a Sysmex CA-1500 automated 
coagulation analyzer (Siemens Diagnostics, 
Leusden, the Netherlands). We measured CRP 
levels by means of an in-house high-sensitivity 
Figure 1. Concentration profiles of air pollutants during the study period: 24-hr mean concentrations for 
PM10 (A), CO (B), NO (C), and NO2 (D) and 8-hr mean concentrations (1200 to 2000 hours) for O3 (E). 
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ELISA with polyclonal rat anti-human CRP 
antibodies (Dako, Glostrup, Denmark) and a 
CRP calibrator (Dako).
Statistical analysis. We present data as 
mean ± SD for continuous variables and as 
counts and percentages for categorical vari-
ables. We performed linear regression analy-
sis between plasma levels and air pollution 
concentration at different periods before 
each blood sampling. We analyzed data in 
R software (version 2.5.1; R Foundation for 
Statistical Computing, Vienna, Austria) using 
generalized additive models with individual 
intercepts for each subject, day of the week as 
a an indicator variable, and penalized spline 
smoothers for date (to adjust for trend and 
seasonality) and meteorologic parameters 
(temperature, pressure, and relative humid-
ity). We used the software to optimize degrees 
of freedom used for the splines, according to 
the procedure described by Wood (2001). We 
used 10 knots as a starting point. The effective 
degrees of freedom for trend ranged from 1 to 
8 for the different models.
A time lag corresponds to a mean con-
centration of an air pollutant that we calcu-
lated from concentrations hourly measured 
within the corresponding time window pre-
ceding each blood sampling, for which we set 
the time of the blood sampling to 0 hours. 
Time lags represent direct effects D0–6, D0–12, 
and D0–24; indirect effects I24–48, I48–72, and 
I72–96; and both direct and indirect effects 
D+I0–96 (Figure 2). In addition, for O3 we 
added the maximum concentration that we 
measured within the 24 hr preceding each 
blood sampling to study the effect of peak 
exposures. The longitudinal study design 
included repeated measures analysis, whereby 
subjects served as their own references. In 
this analysis, plasma levels in 13 blood sam-
ples of each subject were associated with the 
corresponding local concentrations of air 
pollutants. We normalized effects of air pol-
lution on plasma variables and present them 
as percent change of the variable of interest 
for one interquartile range (IQR) of an air 
pollutant (%/IQR) (+ indicates an increase 
of the %/IQR; – indicates a decrease). In this 
model, effects can be compared among all 
air pollutants and all plasma variables. We 
considered a two-sided value of p < 0.05 sta-
tistically significant. For CRP and fibrinogen, 
we determined only indirect effects of air pol-
lution (time lags I24–48, I48–72, and I72–96) 
(Ruckerl et al. 2007). We also performed all 
analyses after excluding smokers (n = 7) or 
women using oral contraceptives (n = 9). We 
calculated the correlation coefficients between 
the concentrations of different air pollutants 
by means of Pearson’s correlation test.
Results
Study population and concentration profiles 
of air pollutants. We included 40 healthy 
subjects with a mean age of 41 years in the 
study (Table 1). Twenty-six women partici-
pated in the study (65% of total). In total, 
there were seven current smokers (18%).
The profile of air pollution concentrations 
throughout the study period shows quite vari-
able levels of air pollutants (Table 2, Figure 1). 
The correlation coefficients between the con-
centrations of different air pollutants were 
> 0.6 per each of the studied time lags and 
were negative between O3 and the other air 
pollutants (–0.4 to –0.6).
Platelet aggregation. The characteristics of 
the subset of subjects in whom platelet aggre-
gation was performed (n = 16) were similar 
to those of the remaining 24 subjects, except 
that there were no users of oral contraceptives 
in this subset of 16 subjects (data not shown). 
We observed indirect effects of air pollution 
on platelet aggregation, represented by a posi-
tive significant association between 5 µmol/L 
ADP-induced maximal aggregation and PM10 
concentrations for time lag I72–96 (+8%/IQR, p 
< 0.01) (Figure 3A). In addition, late aggrega-
tion was significantly associated with PM10 for 
time lags I24–48 and I48–72 (+10 and +6%/IQR, 
respectively; both p < 0.05) and for time lag 
D+I0–96 (+18%/IQR, p < 0.01) (Figure 3B). 
We also observed significant associations 
between maximal aggregation and CO, NO, 
and NO2 for time lag I48–72 (+8, +6, and 
+6%/IQR, respectively; all p < 0.01) and for 
time lag D+I0–96 (+9%/IQR of CO, p < 0.05, 
and +8%/IQR of NO, p < 0.01) (Table 3). 
Similarly, late aggregation was significantly 
associated with CO, NO, and NO2 for these 
time lags (I48–72: +18, +8, and +9%/IQR, 
respectively; D+I0–96: +20, +13, and +16 %/
IQR, respectively; all p < 0.01) (Table 3). In 
addition, we observed a significant associa-
tion between O3 during time lag I48–72 and 
maximal daily concentration of O3 and late 
aggregation (–26 and –16%/IQR, respectively, 
both p < 0.05) (Table 3). We obtained similar 
results when we induced platelet aggregation 
with 2.5 µmol/L ADP, instead of 5 µmol/L 
ADP, and when we performed the analyses in 
nonsmokers only or after exclusion of women 
using oral   contraceptives.
We observed no direct effect of PM10 
on platelet aggregation, because we noted 
no association between the PM10 concen-
tration and maximum platelet aggregation 
or late aggregation for the direct-effect time 
lags D0–6, D0–12, and D0–24 (Figure 3). 
Figure 2. Time lags of estimated exposure to air pollution before blood sampling. The time of each blood 
sampling was set to 0 hours. Time lags represent means of air pollution concentrations that were deter-
mined hourly within the corresponding time window preceding each blood sampling. Dashed arrows rep-
resent direct effects of air pollution (D0–6, D0–12, and D0–24), and solid arrows indirect effects (I24–48, I48–72, 
and I72–96). Time lag D+I0–96 represents the mean concentration within 4 days before blood sampling. 
–96 hr –72 hr –48 hr –24 hr –12 hr– 6 hr 0
Blood sampling
I72–96
I48–72
I24–48
D0–24
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D+I0–96
Table 1. Characteristics of the study population 
(n = 40).
Characteristic  Value
Age (years)  41 ± 15
No. of females   26 (65)
Body mass index (kg/m2)  22.6 ± 2.0
No. of smokers  7 (18)
No. of oral contraceptive users  9 (23)
Blood parameters 
  Fibrinogen (g/L)  2.6 ± 0.5
  CRP (mg/L)  0.6 ± 1.2
Platelet aggregation (n = 16) 
  Maximal aggregation (%)  65 ± 13
  Late aggregation (%)  46 ± 20
Thrombin generation 
  ETP (nM/min)  999 ± 317
  Peak (nM)  141 ± 71
  Lag time (min)  4.2 ± 0.9
Values are no. (%) for categorical variables and mean ± 
SD for continuous variables.
Table 2. Concentrations (µg/m3) of air pollutants 
during the study period.
Air     25th–75th 
pollutant  Median  percentile  Maximum
PM10  29.3  23.8–39.2  110.1
CO  333  276–412  1,283
NO  7  4–15  163
NO2  37  27–48  81
O3  44  21–63  180Rudež et al.
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We confirmed this absence of direct effects 
in vitro, because the addition of various types 
of PM to P200 or whole blood did not lead 
to any changes in light transmittance or 
impedance whole-blood platelet aggregation, 
compared with an aliquot P200 sample to 
which we added no PM. However, a direct 
in vivo effect was suggested for CO, because 
we observed a significant positive association 
with late aggregation (+11, +12, and +11%/
IQR for D0–6, D0–12, and D0–24, respectively; 
all p < 0.05) (Table 3).
Thrombin generation. We observed a 
significant increase in ETP for the gaseous 
pollutants CO, NO, and NO2 at time lags 
representing indirect effects of air pollution 
(I24–48, +2%/IQR of NO and +4%/IQR of 
NO2; I72–96, +3%/IQR of CO and +2%/IQR 
of NO; all p < 0.05) and a significant increase 
in peak thrombin generation (I24–48, +4%/IQR 
of NO and +8%/IQR of NO2, both p < 0.01; 
I72–96, +4%/IQR of NO, p < 0.05) (Table 4). 
In addition, peak thrombin generation was sig-
nificantly increased by 6% per IQR of maximal 
daily concentration of O3 (Table 4). The associ-
ations with PM10 levels were less clear and not 
statistically significant, although the estimates 
for time lags that represent indirect effects on 
ETP were mainly positive (Figure 4A). The lag 
time of thrombin generation was significantly 
lower when the concentrations of gaseous 
pollutants were increased at time lags repre-
senting indirect effects (I24–48, –2%/IQR of 
NO and –3%/IQR of NO2, both p < 0.01; 
I48–72, –2%/IQR of NO2, p < 0.05; I72–96, 
–1%/IQR of NO, p < 0.05), except for the 
time lag D0–24 (+2%/IQR of CO, p < 0.05) 
(Table 4). We observed no clear associations 
between PM10 and peak height or lag time of 
thrombin generation (Figure 4B,C). The asso-
ciations between air pollutants and parameters 
of thrombin generation induced by 5 pM TF 
showed similar associations (data not shown). 
We also obtained similar results for thrombin 
generation parameters when we performed the 
analyses in nonsmokers only or after exclud-
ing women using oral contraceptives (data 
not shown).
Inflammation. Our data suggest that 
there are no indirect effects of PM10 on 
inflammation, because we found no statisti-
cally significant associations between PM10 
concentrations and either CRP or fibrinogen 
levels (Figure 5). We obtained similar results 
for CO, NO, NO2, and O3 (Table 5) and 
when we performed the analyses in nonsmok-
ers only or after excluding women using oral 
contraceptives (data not shown).
Discussion
The main observation of this study was that 
air pollution (except O3) was associated with 
increased platelet aggregation and increased 
thrombin generation, but not with the 
inflammatory markers fibrinogen and CRP. 
The significant associations between various 
air pollutants and increased maximal aggrega-
tion and late aggregation for time lags within 
48–96 hr before blood sampling suggest that 
exposure to air pollution indirectly increases 
blood thrombogenicity. These indirect effects 
may be the result of air pollution–induced 
synthesis of TF (Sun et al. 2008), which can 
increase in vivo platelet reactivity (Kuijpers 
et al. 2008). TF-bearing microparticles have 
also been suggested to contribute to these 
effects on platelets either directly, or indi-
rectly via increased blood coagulability (Morel 
et al. 2006). Another possible mechanism of 
indirect platelet activation might reside in 
pulmonary oxidative stress and the activation 
of subsets of white blood cells that lead to a 
systemic lowering of endothelial- and platelet-
derived nitrogen oxide and concomitant plate-
let activation (Brook 2008). Our results also 
indicate that it is unlikely that blood platelets 
are directly activated by contact with artifi-
cial surfaces of PM because we observed no 
association between platelet aggregation and 
Figure 3. Effects of PM10 on platelet aggregation: estimated effects of PM10 on maximal aggregation (A) 
and late aggregation (B) as percent change from the mean of each individual per IQR increase in PM10 
concentration. Time lags D0–6, D0–12, and D0–24 represent direct effects of PM10 on platelet aggregation, 
and time lags I24–48, I48–72, and I72–96, indirect effects. Time lag D+I0–96 represents the effect of 4-day mean 
concentration of PM10 on platelet aggregation. 
*p < 0.05, **p < 0.01.
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Table 3. Estimated changes of platelet aggregation parameters associated with mean air pollutant levels at various time lags before blood sampling.
  Air pollutant
Time lag  PM10  CO  NO  NO2 O 3
Maximal platelet aggregation
 D 0–6   3.5 (–2.5 to 9.6)  –3.6 (–9.3 to 2.1)  1.3 (–4.4 to 7.1)  –2.3 (–7.3 to 2.7)  7.0 (–1.7 to 15.7)
 D 0–12   3.2 (–2.4 to 8.8)  –4.7 (–11.0 to 1.5)  0.7 (–5.4 to 6.8)  –2.6 (–8.4 to 3.3)  4.1 (–4.6 to 12.8)
 D 0–24  –2.5 (–7.2 to 2.3)  –2.6 (–7.9 to 2.7)  1.9 (–3.0 to 6.9)   –3.0 (–10.3 to 4.3)  4.9 (–6.6 to 16.3)
 I 24–48   3.3 (–1.5 to 8.1)  –1.1 (–7.2 to 4.9)  1.2 (–4.1 to 6.5)  –0.6 (–6.6 to 5.3)  –5.7 (–20.3 to 9.0)
 I 48–72   2.0 (–1.7 to 5.8)  8.4 (2.5 to 14.3)**   6.1 (2.4 to 9.7)**   5.6 (1.5 to 9.7)**  –8.1 (–18.8 to 2.7)
 I 72–96   8.3 (2.5 to 14.1)**  –0.1 (–5.1 to 5.0)  –0.4 (–5.5 to 4.8)  1.2 (–4.5 to 6.9)  –1.6 (–10.4 to 7.3)
  D+I0–96   5.4 (–0.8 to 11.6)  9.5 (1.6 to 17.4)*   8.5 (2.8 to 14.1)**  3.0 (–3.8 to 9.8)  –7.2 (–22.4 to 8.1)
  Maximum          1.1 (–9.5 to 11.7)
Late aggregation
 D 0–6  3.7 (–5.4 to 12.9)  10.5 (0.8 to 20.3)*  8.1 (–1.2 to 17.3)  3.3 (–5.3 to 11.8)  –15.0 (–30.4 to 0.5)
 D 0–12  6.6 (–2.0 to 15.1)  11.6 (1.2 to 21.9)*  8.5 (–0.7 to 17.6)  7.5 (–2.3 to 17.2)  –14.1 (–29.0 to 0.8)
 D 0–24  1.7 (–6.8 to 10.2)  11.2 (1.4 to 21.0)*   8.9 (1.12 to 16.6)*  9.9 (–2.5 to 22.3)  –17.3 (–35.2 to 0.6)
 I 24–48  9.8 (2.4 to 17.2)*  7.5 (–2.2 to 17.1)  5.5 (–1.5 to 12.4)  1.9 (–9.0 to 12.7)  –18.4 (–39.0 to 2.2)
 I 48–72  6.4 (0.7 to 12.2)*  18.1 (8.4 to 27.8)**  7.9 (2.3 to 13.4)**  8.9 (2.6 to 15.2)**  –26.0 (–44.1 to –7.8)**
 I 72–96  8.2 (–1.2 to 17.6)  4.2 (–5.5 to 13.9)  3.4 (–5.7 to 12.6)  4.8 (–4.3 to 13.9)  1.2 (–14.8 to 17.3)
  D+I0–96  18.1 (9.1 to 27.1)**  20.4 (8.4 to 32.4)**  13.0 (4.9 to 21.1)**  16.1 (5.0 to 27.2)**  –17.1 (–40.8 to 6.7)
  Maximum          –16.4 (–31.0 to –1.8)*
Data are percent change of 5 µmol/L ADP-induced maximal platelet aggregation and late aggregation (6 min after maximum), with 95% confidence intervals in parentheses. Values are 
based on hourly measurements from a monitor located within the city center of Rotterdam. Effects for time lags are presented for all air pollutants; for O3 we additionally present the 
effect of the maximum concentration in the 24 hr preceding blood sampling. Blood was drawn from all subjects between 0900 and 1100 hours.
*p < 0.05; **p < 0.01.Air pollution in hemostasis and inflammation
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PM concentrations for time lags representing 
direct effects. We confirmed these findings 
with our in vitro experiments, in which we 
saw no direct effects (0–2 hr) of the addition 
of PM on platelet aggregation.
Results for thrombin generation suggest 
that air pollution leads to an overall tendency 
toward a hypercoagulable state, because both 
ETP and peak thrombin generation were 
increased after exposure to higher levels of 
gaseous air pollutants. Again, these indirect 
effects on thrombin generation may be caused 
by elevated levels of TF. Notably, only gas-
eous pollutants, and not PM10, were associ-
ated with these indirect effects. The gaseous 
air pollutants, especially NO2 and CO, can be 
considered markers for motor vehicle traffic 
and have been shown to be highly correlated 
with ultrafine particles (Cyrys et al. 2003). It 
is mainly this subset of ultrafine particles from 
the overall PM air pollution that has an effect 
on thrombin generation (Spronk HM, ten 
Cate H, unpublished data). This could explain 
why only the gaseous pollutants, and not 
PM10 mass concentration, was associated with 
thrombin generation in this study. Another 
mechanism may involve altered synthesis of 
pro- and anticoagulant proteins. However, 
previous studies on air pollution–related 
changes in plasma levels of PT, factor VII, 
antithrombin, protein C, and protein S are 
conflicting (Baccarelli et al. 2007; Pekkanen 
et al. 2000; Ruckerl et al. 2006; Seaton et al. 
1999). In our study, changes in thrombin gen-
eration were independent of the changes in 
fibrinogen concentrations. Because thrombin 
generation depends not only on fibrinogen but 
also on other pro- and anticoagulant proteins, 
this suggests that air pollution can induce 
changes in hemostatic balance that are not 
inflammation driven.
In our study, air pollution was not associ-
ated with systemic inflammation. We mea-
sured fibrinogen and CRP, two sensitive 
inflammatory markers that are consistently 
associated with cardiovascular risk. The results 
from epidemiologic studies on air pollution 
and inflammation are conflicting, as are those 
from laboratory studies on the inflammatory 
responses in human volunteers or animals 
after experimentally controlled exposure to 
air pollution (Baccarelli et al. 2007; Chuang 
et al. 2007; Maier et al. 2008; Nemmar et al. 
2003; Seaton et al. 1999). Because fibrinogen 
Table 4. Estimated changes of thrombin generation associated with mean air pollutant levels at various time lags before blood sampling.
  Air pollutant
Time lag  PM10  CO  NO  NO2 O 3
ETP
 D 0–6  –0.2 (–2.6 to 2.1)  –1.5 (–3.7 to 0.8)  –0.4 (–2.3 to 1.5)  –1.2 (–3.6 to 1.2)  3.2 (–0.3 to 6.7)
 D 0–12  –0.2 (–2.2 to 1.8)  –1.1 (–3.4 to 1.1)  –0.4 (–2.0 to 1.1)  –0.2 (–2.8 to 2.4)  0.8 (–2.8 to 4.4)
 D 0–24  –0.7 (–2.7 to 1.4)  –1.5 (–3.9 to 0.9)  –0.3 (–2.2 to 1.6)  0.3 (–2.5 to 3.1)  0.3 (–3.8 to 4.5)
 I 24–48  –0.2 (–2.3 to 1.9)  –0.7 (–3.4 to 2.0)  1.9 (0.1 to 3.7)*  3.5 (0.2 to 6.8)*  –0.9 (–5.4 to 3.6)
 I 48–72  1.9 (–0.2 to 4.0)  0.8 (–1.9 to 3.4)  0.8 (–0.8 to 2.5)  2.1 (–1.0 to 5.2)  –0.6 (–4.5 to 3.3)
 I 72–96  1.5 (–1.1 to 4.2)  3.5 (0.8 to 6.2)*  2.1 (0.2 to 4.0)*  0.8 (–1.9 to 3.5)  –0.6 (–4.1 to 3.0)
  D+I0–96  0.7 (–2.3 to 3.8)  0.8 (–2.7 to 4.3)  1.7 (–1.1 to 4.5)  1.1 (–1.7 to 4.0)  1.0 (–3.2 to 5.2)
  Maximum            2.3 (–1.2 to 5.8)
Peak
 D 0–6  –0.8 (–4.8 to 3.1)  –2.5 (–6.3 to 1.3)  –0.4 (–3.6 to 2.8)  –1.5 (–5.5 to 2.5)  5.7 (–0.2 to 11.7)
 D 0–12  –0.7 (–4.1 to 2.6)  –1.9 (–5.7 to 1.9)  –0.4 (–3.1 to 2.3)  –0.7 (–5.1 to 3.7)  2.8 (–3.4 to 8.9)
 D 0–24  –1.6 (–5.0 to 1.8)  –3.3 (–7.3 to 0.7)  –0.6 (–3.9 to 2.6)  –0.6 (–5.3 to 4.1)  2.6 (–4.8 to 9.9)
 I 24–48  –0.2 (–3.7 to 3.3)  –1.3 (–6.1 to 3.6)  4.1 (1.1 to 7.2)**  8.0 (2.4 to 13.6)**  0.2 (–7.3 to 7.8)
 I 48–72  1.9 (–1.6 to 5.4)  –0.5 (–5.0 to 4.0)  1.2 (–1.6 to 4.0)  3.7 (–1.5 to 9.0)  1.4 (–5.1 to 8.0)
 I 72–96  0.2 (–4.2 to 4.6)  3.8 (–0.8 to 8.4)  3.5 (0.4 to 6.7)*  –0.2 (–4.8 to 4.4)  2.6 (–3.3 to 8.5)
  D+I0–96  –1.9 (–6.9 to 3.2)  –1.7 (–7.5 to 4.2)  3.1 (–1.7 to 7.8)  1.0 (–4.1 to 6.0)  6.6 (–0.7 to 13.8)
  Maximum            6.3 (0.3 to 12.3)*
Lag time
 D 0–6  0.1 (–1.4 to 1.7)  1.0 (–0.5 to 2.5)  –0.1 (–1.4 to 1.1)  0.0 (–1.6 to 1.6)  –0.3 (–2.6 to 2.0)
 D 0–12  0.2 (–1.2 to 1.5)  1.0 (–0.5 to 2.5)  0.0 (–1.1 to 1.0)  0.0 (–1.8 to 1.7)  –0.4 (–2.7 to 2.0)
 D 0–24  1.1 (–0.2 to 2.4)  1.6 (0.1 to 3.1)*  0.6 (–0.6 to 1.8)  0.2 (–1.6 to 2.0)  –0.3 (–2.9 to 2.3)
 I 24–48  0.1 (–1.3 to 1.5)  0.4 (–1.3 to 2.2)  –1.8 (–2.9 to –0.7)**  –3.1 (–5.1 to –1.0)**  3.0 (0.4 to 5.7)*
 I 48–72  0.0 (–1.4 to 1.4)  –1.0 (–2.7 to 0.7)  –0.8 (–1.8 to 0.3)  –2.5 (–4.3 to –0.6)*  1.2 (–1.1 to 3.6)
 I 72–96  0.6 (–1.2 to 2.3)  –1.5 (–3.2 to 0.2)  –1.4 (–2.6 to –0.2)*  0.0 (–1.8 to 1.7)  0.6 (–1.6 to 2.8)
  D+I0–96  1.2 (–0.7 to 3.2)  0.1 (–2.1 to 2.2)  –1.1 (–2.8 to 0.5)  –0.7 (–2.5 to 1.1)  0.6 (–2.0 to 3.2)
  Maximum            –1.2 (–3.5 to 1.0)
Percent change of thrombin with their 95% confidence intervals indicated in parentheses. Thrombin generation was induced with 1 pM TF and 4 µmol/L phospholipids. Values are based 
on hourly measurements from a monitor located within the city center of Rotterdam. Effects for time lags are presented for all air pollutants; for O3 we additionally present the effect of 
the maximum concentration in the 24 hr preceding blood sampling. Blood was drawn from subjects between 0900 and 1100 hours. 
*p < 0.05; **p < 0.01.
Figure 4. Effects of PM10 on thrombin generation: estimated effects of PM10 on ETP (A), peak height (B), and lag time (C) as percent change from the mean for 
each individual per interquartile increase in PM10 concentration. Time lags D0–6, D0–12, and D0–24 represent direct effects of PM10 on thrombin generation, and time 
lags I24–48, I48–72, and I72–96, indirect effects. Time lag D+I0–96 represents the effect of 4-day mean concentration of PM10 on thrombin generation. 
*p < 0.05. 
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and CRP do not reflect all aspects of inflam-
mation, measuring other inflammatory mark-
ers, such as interleukin 6 and tumor necrosis 
factor-α, may still reveal associations between 
air pollution and inflammation (Mutlu et al. 
2007; Ruckerl et al. 2006).
Most of the significant associations 
observed in the present study concern more 
than one air pollutant, especially in the case 
of late aggregation, which was associated with 
all studied air pollutants. The correlation coef-
ficients between the concentrations of air 
pollutants were moderate and mainly posi-
tive (> 0.6), except between O3 and the other 
air pollutants (–0.4 to –0.6). This probably 
explains the observed opposite effects of O3 
on most of the plasma variables, compared 
with the effects of PM10, CO, NO, and NO2. 
However, when we analyzed these effects of O3 
in a two-pollutant model with PM10, only the 
effects of PM10 remained statistically signifi-
cant with similar estimates (data not shown), 
suggesting that PM10, rather than O3, is 
responsible for the observed effects on platelet 
aggregation and thrombin generation. This was 
in contrast to the results of the two-pollutant 
models that combined PM10 with CO, NO, 
or NO2, which indicated that effects of these 
gases are mainly independent of the effects 
of PM10 (data not shown). Nevertheless, it 
remains difficult to completely discern causal 
air pollutant(s) from their surrogate markers.
The present study was designed to repre-
sent a real-life urban situation. Our approach 
combines several strengths. First, we have 
evaluated the effects of air pollution on blood 
parameters over a period of 1 year. In this 
longitudinal study design, participants were 
their own controls, which ensures the most 
reliable estimates of acute effects of exposure 
to air pollution. Second, we selected subjects 
with a similar exposure to local air pollution. 
Third, several studies have shown that central 
site measurements correlate well with personal 
exposures for longitudinal acute effects (Janssen 
et al. 1998, 2005; World Health Organization 
2006). Although the study participants have 
spent a significant amount of time living or 
working in Rotterdam during the study period, 
their estimated exposure to air pollution may 
vary. However, we did not design our study to 
correct for these possible variations. Another 
limitation of the study is that the PM10 mass 
concentration is a poor measure of its biologi-
cal activity, because the corresponding par-
ticles are heterogeneous in composition (e.g., 
endotoxins and metals) and may therefore trig-
ger different biological responses (Brook et al. 
2004). All subjects in this study were healthy 
volunteers. The observed effects of air pollution 
on hemostasis may differ (being possibly more 
pronounced) in subjects with coronary artery 
disease or subjects at higher risk for this disease.
In conclusion, our data show a significant 
association between exposure to air pollution 
and systemic prothrombotic tendency of the 
blood via increased platelet aggregation and 
thrombin generation in a healthy population. 
This association may point to a relevant bio-
logical mechanism that contributes to the 
risk association between air pollution and 
cardiovascular disease. 
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